0001628280-24-013993.txt : 20240401
0001628280-24-013993.hdr.sgml : 20240401
20240401151824
ACCESSION NUMBER: 0001628280-24-013993
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231009
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Brady
CENTRAL INDEX KEY: 0002002615
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11504
FILM NUMBER: 24808604
MAIL ADDRESS:
STREET 1: C/O CHAMPIONS ONCOLOGY, INC.
STREET 2: ONE UNIVERSITY PLAZA STE 307
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC.
CENTRAL INDEX KEY: 0000771856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521401755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 410-369-0365
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC.
DATE OF NAME CHANGE: 20070220
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS SPORTS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: INTERNATIONAL GROUP INC
DATE OF NAME CHANGE: 19860319
4
1
wk-form4_1711999092.xml
FORM 4
X0508
4
2023-10-09
0
0000771856
CHAMPIONS ONCOLOGY, INC.
CSBR
0002002615
Davis Brady
C/O CHAMPIONS ONCOLOGY, INC.
ONE UNIVERSITY PLAZA, SUITE 307
HACKENSACK
NJ
07601
0
1
0
0
President
0
Option to purchase Common Stock
6.50
2023-10-09
4
A
0
135000
6.50
A
2033-10-09
Common Stock
135000
135000
D
Option to purchase Common Stock
6.50
2023-10-09
4
A
0
7500
6.50
A
2033-10-09
Common Stock
7500
142500
D
Option to purchase Common Stock
6.50
2023-10-09
4
A
0
68000
6.50
A
2033-10-09
Common Stock
68000
210500
D
The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively.
The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024.
The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period.
/s/ Brady Davis
2024-04-01